Single-cell sequencing technologies have transformed our understanding of the heterogeneity within breast cancer tumors. By analyzing the genetic material of individual cells within a tumor, researchers can identify distinct subpopulations of cancer cells, each potentially responding differently to treatment. This insight is crucial for the development of combination therapies that can target multiple pathways simultaneously, preventing drug resistance and improving patient outcomes.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.